AU2002223106A1 - Stimulation of thymus for vaccination development - Google Patents

Stimulation of thymus for vaccination development

Info

Publication number
AU2002223106A1
AU2002223106A1 AU2002223106A AU2310602A AU2002223106A1 AU 2002223106 A1 AU2002223106 A1 AU 2002223106A1 AU 2002223106 A AU2002223106 A AU 2002223106A AU 2310602 A AU2310602 A AU 2310602A AU 2002223106 A1 AU2002223106 A1 AU 2002223106A1
Authority
AU
Australia
Prior art keywords
cells
thymus
ofthe
cell
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002223106A
Other languages
English (en)
Inventor
Richard Boyd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norwood Immunology Ltd
Original Assignee
Norwood Immunology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR0745A external-priority patent/AUPR074500A0/en
Priority claimed from US09/755,965 external-priority patent/US20010046486A1/en
Application filed by Norwood Immunology Ltd filed Critical Norwood Immunology Ltd
Publication of AU2002223106A1 publication Critical patent/AU2002223106A1/en
Assigned to NORWOOD IMMUNOLOGY LTD reassignment NORWOOD IMMUNOLOGY LTD Request for Assignment Assignors: MONASH UNIVERSITY
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002223106A 2000-10-13 2001-10-12 Stimulation of thymus for vaccination development Abandoned AU2002223106A1 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US79528600A 2000-10-13 2000-10-13
US79530200A 2000-10-13 2000-10-13
US09/795286 2000-10-13
AUPR0745A AUPR074500A0 (en) 2000-10-13 2000-10-13 Treatment of t cell disorders
AUPR0745 2000-10-13
US09/795302 2000-10-13
US09/755,965 US20010046486A1 (en) 2000-04-17 2001-01-05 Stimulation of thymus for vaccination development
US09/755965 2001-01-05
US09/965394 2001-09-26
US09/965,394 US20020086000A1 (en) 1999-04-15 2001-09-26 Stimulation of thymus for vaccination development
PCT/IB2001/002350 WO2002030320A2 (en) 2000-10-13 2001-10-12 Stimulation of thymus for vaccination development

Publications (1)

Publication Number Publication Date
AU2002223106A1 true AU2002223106A1 (en) 2002-04-22

Family

ID=27507496

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002223106A Abandoned AU2002223106A1 (en) 2000-10-13 2001-10-12 Stimulation of thymus for vaccination development

Country Status (11)

Country Link
US (1) US20020086000A1 (de)
EP (1) EP1355653A4 (de)
JP (1) JP2004517051A (de)
CN (1) CN1505522A (de)
AP (1) AP2003002797A0 (de)
AU (1) AU2002223106A1 (de)
BR (1) BR0114641A (de)
CA (1) CA2462027A1 (de)
IL (1) IL155410A0 (de)
NZ (1) NZ525825A (de)
WO (1) WO2002030320A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004103271A2 (en) * 2003-04-18 2004-12-02 Norwood Immunology, Ltd. Disease prevention and vaccination prior to thymic reactivations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE424217T1 (de) * 1997-12-11 2009-03-15 Univ Maryland Biotech Inst Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
US20010046486A1 (en) * 2000-04-17 2001-11-29 Boyd Richard L. Stimulation of thymus for vaccination development
AUPP977899A0 (en) * 1999-04-15 1999-05-13 Monash University Improvement of t cell mediated immunity

Also Published As

Publication number Publication date
EP1355653A4 (de) 2006-05-31
CN1505522A (zh) 2004-06-16
CA2462027A1 (en) 2002-04-18
IL155410A0 (en) 2003-11-23
AP2003002797A0 (en) 2003-06-30
BR0114641A (pt) 2004-01-20
EP1355653A2 (de) 2003-10-29
WO2002030320A3 (en) 2002-06-20
JP2004517051A (ja) 2004-06-10
NZ525825A (en) 2005-05-27
US20020086000A1 (en) 2002-07-04
WO2002030320A2 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
CA2462758A1 (en) Diagnostic indicator of thymic function
WO2002030259A2 (en) Disease prevention by reactivation of the thymus
US20020119128A1 (en) Graft acceptance through manipulation of thymic regeneration
WO2002031110A2 (en) Hematopoietic stem cell gene therapy
AU2002216323B2 (en) Disease prevention by reactivation of the thymus
AU2002225245B2 (en) Improvement of graft acceptance through manipulation of thymic regeneration
WO2002030257A9 (en) Normalization of defective t cell responsiveness through manipulation of thymic regeneration
US20020086003A1 (en) Stimulation of thymus for vaccination development
AU2002223106A1 (en) Stimulation of thymus for vaccination development
AU2002216320C1 (en) Hematopoietic stem cell gene therapy
AU2007202609A1 (en) Stimulation of thymus for vaccination development
ZA200303684B (en) Stimulation of thymus for vaccination development
AU2002225245A1 (en) Improvement of graft acceptance through manipulation of thymic regeneration
US20020110540A1 (en) Disease prevention by reactivation of the thymus
US20040037816A1 (en) Graft acceptance through manipulation of thymic regeneration
AU2002216323A1 (en) Disease prevention by reactivation of the thymus
US20040037817A1 (en) Normalization of defective T cell responsiveness through manipulation of thymic regeneration
AU2007202610A1 (en) Normalization of defective T cell responsiveness through manipulation of thymic regeneration
AU2002216320A1 (en) Hematopoietic stem cell gene therapy
ZA200303685B (en) Hematopoietic stem cell gene therapy.

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted